Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005557 · ClinicalTrials.gov registry record

Epidemiology of Sleep-Disordered Breathing in Adults

A clinical trial of Cardiovascular Disease and Mood Disorders, sponsored by University of Wisconsin, Madison.

Active
Registry status
1,545
Enrollment target
1
Study location

NCT00005557: Active study of Cardiovascular Disease and Mood Disorders, sponsored by University of Wisconsin, Madison.

NCT00005557 is a study of Cardiovascular Disease and Mood Disorders that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 1,545 participants, below the 2,686-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005557, a study of Cardiovascular Disease and Mood Disorders, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.

ACTIVE NOT RECRUITING
Registry status
1,545 participants
Enrollment target
1
Study location

Study Summary

To characterize the natural history and biologic spectrum of sleep disordered breathing (SDB) and other sleep problems and disorders, and test hypotheses regarding the causes and consequences of SDB and other sleep problems and disorders.

Primary Outcome

Overnight polysomnography is used to assess sleep pathology. Questionnaires are used to assess sleep habits. A variety of clinical and laboratory assessments measure cardiovascular and cognitive outcomes.

Study Locations (1)

Wisconsin

  • University of Wisconsin Hospital and Clinics - Madison

Trial Details

FieldValue
Enrollment Target 1,545 participants
Start Date 1999-04
Est. Completion 2031-04
University of Wisconsin, Madison

1,039 total trials

What the registry record for NCT00005557 still lists

NCT00005557 is an observational study that tracks outcomes without assigning an intervention. Its 1,545 participants enrollment target places it among the larger protocols in the corpus, below the 2,686-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (42% lower).

The record links to 5 conditions, with Cardiovascular Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00005557 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00005557 about?

NCT00005557 is a clinical study titled "Epidemiology of Sleep-Disordered Breathing in Adults". To characterize the natural history and biologic spectrum of sleep disordered breathing (SDB) and other sleep problems and disorders, and test hypotheses regarding the causes and consequences of SDB and other sleep problems and disorders.

What is the current status of trial NCT00005557?

This trial is currently active not recruiting. The enrollment target is 1,545 participants. The study started on 1999-04. Estimated completion is 2031-04.

What conditions does trial NCT00005557 study?

This clinical trial studies the following conditions: Cardiovascular Disease, Mood Disorders, Sleep Disorders, Cerebrovascular Disorders, Neurologic Disorders.

Who is sponsoring clinical trial NCT00005557?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00005557 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00005557's enrollment target sits among peer trials

1,545 25th of 137 higher than 113 of 137 other Cardiovascular Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06729775 · 1,546 participants · NA

    Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back

  • NCT03435796 · 1,541 participants · Phase 2

    Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • NCT02650622 · 1,550 participants

    Genetic and Metabolic Disease in Children

  • NCT03961945 · 1,550 participants · NA

    Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00005557, the US trial registry maintained by the National Library of Medicine. NCT00005557 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.